Search

Displaying results 9921 - 9930 of 10000 in total
  1. Drug

    Utibaprilat

    go.drugbank.com/drugs/DB20873
    Experimental

    The usage of the INN stem '-prilat' in the name indicates that Utibaprilat is a angiotensin-converting enzyme inhibitor. Utibaprilat has a monoisotopic molecular weight of 421.17 Da.

  2. Drug

    Enzaplatovir

    go.drugbank.com/drugs/DB21042
    Experimental

    The usage of the INN stem '-atovir' in the name indicates that Enzaplatovir is a RSV fusion protein inhibitor. Enzaplatovir has a monoisotopic molecular weight of 377.15 Da.

  3. Drug

    GenSci148

    go.drugbank.com/drugs/DB33957
    Experimental

    GenSci148 is under investigation in clinical trial NCT07817615 (A Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal

  4. Drug

    Sodium tripolyphosphate

    go.drugbank.com/drugs/DB11493
    InvestigationalVet approved

    Sodium tripolyphosphate is an inorganic compound with formula Na5P3O10 and the sodium salt of the polyphosphate penta-anion.

  5. Drug

    Ficlatuzumab

    go.drugbank.com/drugs/DB11680
    Investigational

    Ficlatuzumab has been used in trials studying the treatment of Acute Myeloid Leukemia, Non-small Cell Lung Cancer, Mullerian Mixed Tumor of Ovary, Relapsed Acute Myeloid Leukemia, and Refractory Acute

  6. Drug

    Onatasertib

    go.drugbank.com/drugs/DB12570
    Investigational

    Onatasertib (CC-223) has been used in trials studying the treatment and basic science of Multiple Myeloma, Glioblastoma Multiforme, HepatoCellular Carcinoma, Non-small Cell Lung Cancer, and Diffuse Large

  7. Drug

    Cyclohexanone

    go.drugbank.com/drugs/DB02060
    Experimental

    It is a colorless, oily liquid with an acetone-like smell.

  8. Drug

    Pafuramidine

    go.drugbank.com/drugs/DB06532
    Investigational

    Pafuramidine, a prodrug of furamidine, currently has orphan status for Pneumocystis jiroveci pneumonia.

  9. Drug

    Epothilone D

    go.drugbank.com/drugs/DB01873
    Investigational

  10. Drug

    RPI-78M

    go.drugbank.com/drugs/DB05740
    Experimental

    RPI-78M is being developed for the treatment of multiple sclerosis (MS). Other neurological disorders that may be served by RPI-78M include myasthenia gravis (MG), muscular dystrophy (MD) and amyotrophic lateral sclerosis (ALS).